☰

George A. Vielhauer, Ph.D. - Publications

Affiliations: 
2004 University of Arizona, Tucson, AZ 
Area:
Pharmacology
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Goldson TM, Vielhauer G, Staub E, Miller S, Shim H, Hagedorn CH. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells. Molecular Carcinogenesis. 46: 71-84. PMID 17091471 DOI: 10.1002/Mc.20276  0.372
2004 Fujino H, Vielhauer GA, Regan JW. Prostaglandin E2 selectively antagonizes prostaglandin F2alpha-stimulated T-cell factor/beta-catenin signaling pathway by the FPB prostanoid receptor. The Journal of Biological Chemistry. 279: 43386-91. PMID 15280380 DOI: 10.1074/Jbc.M408276200  0.54
2004 Vielhauer GA, Fujino H, Regan JW. Cloning and localization of hFP(S): a six-transmembrane mRNA splice variant of the human FP prostanoid receptor. Archives of Biochemistry and Biophysics. 421: 175-85. PMID 14984197 DOI: 10.1016/J.Abb.2003.10.021  0.474
2002 Weber TJ, Markillie LM, Chrisler WB, Vielhauer GA, Regan JW. Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2alpha receptor. Molecular Carcinogenesis. 35: 163-72. PMID 12489107 DOI: 10.1002/Mc.10079  0.535
2001 Thompson EJ, Gupta A, Vielhauer GA, Regan JW, Bowden GT. The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1. Neoplasia (New York, N.Y.). 3: 402-10. PMID 11687951 DOI: 10.1038/Sj.Neo.7900182  0.52
Show low-probability matches.